Loss-of-function variant of the immunoregulator TMEM176B is associated with progression to ESKD in SLE
Authors:
Open Access
- 1 July 2026
- journal article
- Published by BMJ in Lupus Science & Medicine
- Vol. 13 (2) , e002243
Abstract
No abstract availableFunding Information
- ANII (FCE_1_2025_1_186822)
- ANII (FCE_3_2024_1_180768)
This publication has 5 references indexed in Scilit:
- NLRP3 Inflammasome as Potential Predictor of Non-Responsiveness to Immunosuppressive Treatment in Lupus NephritisInternational Journal of Molecular Sciences, 2025
- Lupus nephritisNature Reviews Disease Primers, 2025
- The intracellular cation channel TMEM176B as a dual immunoregulatorFrontiers in Cell and Developmental Biology, 2022
- PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus diseaseScience Advances, 2022
- The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activationJournal of Cancer Research and Clinical Oncology, 2022